Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China · Delayed Price · Currency is CNY 20.73
-0.14 (-0.67%)
Aug 26, 2026, 3:04 PM CST
SHE:000739 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 9,162 | 9,784 | 12,022 | 11,474 | 10,545 | 8,943 |
Revenue Growth | -16.99% | -18.62% | 4.77% | 8.81% | 17.92% | 13.49% |
Gross Profit Gross Profit Growth | 2,515 | 2,486 | 2,796 | 2,853 | 2,470 | 2,364 |
Operating Income Operating Income Growth | 924.29 | 877.83 | 1,012 | 1,078 | 906.8 | 959.39 |
Net Income Net Income Growth | 850.01 | 890.68 | 1,031 | 1,055 | 989.17 | 955.55 |
Earnings Per Share EPS Growth | 0.74 | 0.77 | 0.89 | 0.90 | 0.84 | 0.81 |
EPS Growth | -11.87% | -12.87% | -1.78% | 7.12% | 3.91% | 17.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceuticals Pharmaceuticals Growth | 9,101 | 9,728 | 11,957 | 11,440 | 10,545 | 8,943 |
Unallocated Other Operations Unallocated Other Operations Growth | 61.7 | 55.48 | 65.35 | 33.92 | - | - |
Total Total Growth | 9,162 | 9,784 | 12,022 | 11,474 | 10,545 | 8,943 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,058 | 3,786 | 3,662 | 3,581 | 3,553 | 2,625 |
Total Debt Total Debt Growth | 1,533 | 1,520 | 909.47 | 920.3 | 837.3 | 474.33 |
Net Cash (Debt) Net Cash Growth | 1,525 | 2,266 | 2,752 | 2,660 | 2,716 | 2,151 |
Net Cash Growth | -36.12% | -17.66% | 3.45% | -2.04% | 26.27% | 8.61% |
Net Cash Per Share Net Cash Per Share Growth | 1.32 | 1.96 | 2.37 | 2.28 | 2.31 | 1.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 887.35 | 1,220 | 1,209 | 1,031 | 1,326 | 611.75 |
Capital Expenditures CapEx Growth | -449.52 | -386.21 | -460.75 | -630.47 | -509.11 | -701.92 |
Free Cash Flow Free Cash Flow Growth | 437.83 | 833.99 | 748.01 | 400.9 | 817 | -90.18 |
Free Cash Flow Growth | 87.00% | 11.49% | 86.58% | -50.93% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 27.45% | 25.41% | 23.26% | 24.86% | 23.42% | 26.43% |
Operating Margin | 10.09% | 8.97% | 8.42% | 9.39% | 8.60% | 10.73% |
Pretax Margin | 11.23% | 10.90% | 10.01% | 10.50% | 9.60% | 12.46% |
Profit Margin | 9.28% | 9.10% | 8.58% | 9.20% | 9.38% | 10.69% |
FCF Margin | 4.78% | 8.52% | 6.22% | 3.49% | 7.75% | -1.01% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.476 | 0.586 | 0.356 | 0.317 | 0.297 | 0.285 |
Dividend Per Share Growth | 64.68% | 64.68% | 12.35% | 6.70% | 4.21% | 17.28% |
Dividend Yield | 2.26% | 3.65% | 2.32% | 2.23% | 1.52% | 0.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 28.30 | 20.98 | 18.27 | 17.05 | 25.50 | 43.28 |
Forward PE | 16.30 | 12.61 | 14.93 | 12.47 | 22.39 | 32.10 |
P/FCF Ratio | 53.66 | 22.40 | 25.18 | 44.89 | 30.87 | - |
PS Ratio | 2.56 | 1.91 | 1.57 | 1.57 | 2.39 | 4.62 |